62 related articles for article (PubMed ID: 31151416)
1. A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas.
Creemers A; Ebbing EA; Pelgrim TC; Lagarde SM; van Etten-Jamaludin FS; van Berge Henegouwen MI; Hulshof MCCM; Krishnadath KK; Meijer SL; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
Sci Rep; 2018 Sep; 8(1):13281. PubMed ID: 30185893
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease.
Dos Santos Cunha AC; Simon AG; Zander T; Buettner R; Bruns CJ; Schroeder W; Gebauer F; Quaas A
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6917-6929. PubMed ID: 36826594
[TBL] [Abstract][Full Text] [Related]
3. ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal Adenocarcinoma.
Zhang L; Zheng Y; Chien W; Ziman B; Billet S; Koeffler HP; Lin DC; Bhowmick NA
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001638
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma.
Barroux M; Househam J; Lakatos E; Ronel T; Baker AM; Salié H; Mossner M; Smith K; Kimberley C; Nowinski S; Berner A; Gunasri V; Jansen M; Caravagna G; Steiger K; Slotta-Huspenina J; Weichert W; Alberstmeier M; Chain B; Friess H; Bengsch B; Schmid R; Siveke J; Quante M; Graham T
Res Sq; 2023 Apr; ():. PubMed ID: 37090678
[TBL] [Abstract][Full Text] [Related]
5. Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinoma.
Raters VM; Gebauer F; Löser H; Schröder W; Schlösser HA; Fuchs H; Bruns C; Quaas A; Zander T
Front Oncol; 2023; 13():1249172. PubMed ID: 38045001
[TBL] [Abstract][Full Text] [Related]
6. Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma.
Damanakis AI; Wahler I; Fuchs H; Löser H; Schröder W; Zander T; Chon SH; Bruns C; Quaas A; Gebauer F
Sci Rep; 2022 Dec; 12(1):20745. PubMed ID: 36456612
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective.
Hu XM; Li ZX; Lin RH; Shan JQ; Yu QW; Wang RX; Liao LS; Yan WT; Wang Z; Shang L; Huang Y; Zhang Q; Xiong K
Front Cell Dev Biol; 2021; 9():634690. PubMed ID: 33748119
[TBL] [Abstract][Full Text] [Related]
8. Escape from X chromosome inactivation and female bias of autoimmune diseases.
Mousavi MJ; Mahmoudi M; Ghotloo S
Mol Med; 2020 Dec; 26(1):127. PubMed ID: 33297945
[TBL] [Abstract][Full Text] [Related]
9. A 22-amino-acid peptide regulates tight junctions through occludin and cell apoptosis.
Zhu M; Lu J; Shen J; Fei L; Chen D
PeerJ; 2020; 8():e10147. PubMed ID: 33194394
[TBL] [Abstract][Full Text] [Related]
10. ATP synthase modulation leads to an increase of spare respiratory capacity in HPV associated cancers.
Kirschberg M; Heuser S; Marcuzzi GP; Hufbauer M; Seeger JM; Đukić A; Tomaić V; Majewski S; Wagner S; Wittekindt C; Würdemann N; Klussmann JP; Quaas A; Kashkar H; Akgül B
Sci Rep; 2020 Oct; 10(1):17339. PubMed ID: 33060693
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of X-linked inhibitor of apoptosis protein in patients with gastrointestinal tract cancers: A meta-analysis.
Ieong C; Yang H; Ma J; Lai W
Medicine (Baltimore); 2020 Feb; 99(9):e18497. PubMed ID: 32118702
[TBL] [Abstract][Full Text] [Related]
12. Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma.
Schiffmann LM; Göbel H; Löser H; Schorn F; Werthenbach JP; Fuchs HF; Plum PS; Bludau M; Zander T; Schröder W; Bruns CJ; Kashkar H; Quaas A; Gebauer F
BMC Cancer; 2019 May; 19(1):531. PubMed ID: 31151416
[TBL] [Abstract][Full Text] [Related]
13. The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation.
Humphries MP; Craig SG; Kacprzyk R; Fisher NC; Bingham V; McQuaid S; Murray GI; McManus D; Turkington RC; James J; Salto-Tellez M
BMC Cancer; 2020 Jun; 20(1):500. PubMed ID: 32487090
[TBL] [Abstract][Full Text] [Related]
14. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.
Gabriel E; Attwood K; Du W; Tuttle R; Alnaji RM; Nurkin S; Malhotra U; Hochwald SN; Kukar M
JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488
[TBL] [Abstract][Full Text] [Related]
15. X-linked inhibitor of apoptosis protein is a prognostic marker for a favorable outcome in three identified subsets in resectable adenocarcinoma of the pancreas.
Knipper K; Lyu SI; Goebel H; Damanakis AI; Zhao Y; Bruns CJ; Schmidt T; Kashkar H; Quaas A; Schiffmann LM; Popp FC;
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5531-5538. PubMed ID: 36472768
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers.
Bobryshev YV; Orekhov AN; Chistiakov DA
Curr Pharm Des; 2015; 21(23):3402-16. PubMed ID: 25758856
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal.
Visser BC; Venook AP; Patti MG
Surg Oncol; 2003 Jul; 12(1):1-7. PubMed ID: 12689665
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
